Patents
Patents for C07C 233 - Carboxylic acid amides (28,881)
02/2006
02/14/2006US6998409 Drugs for treating chronic pain; stereoisomers; chemical synthesis from intermediates; nontoxic
02/14/2006CA2363145C Oxamic acids and derivatives as thyroid receptor ligands
02/14/2006CA2245197C Unsaturated derivatives in position -4 of 6-tert-butyl-1, 1-dimethylindan and their use in human or veterinary medicine and in cosmetics
02/09/2006US20060030618 Vanilloid receptor ligands and their use in treatments
02/09/2006US20060030553 Cell adhesion inhibitors
02/09/2006CA2573223A1 Aromatic compound
02/08/2006EP1623972A1 Solid n-acylalanine or salts thereof
02/08/2006EP1406865B1 Succinic acid derivatives
02/08/2006EP1144348B1 Lta 4 hydrolase inhibitors
02/08/2006EP1117634B1 Dialkyl quaternary ammonium derivatives of oils, fatty acids, triglycerides and their use in personal care products
02/08/2006CN1732161A 1,3-diamino-2-hydroxypropane pro-drug derivatives
02/08/2006CN1732156A Biphenyl derivatives and their use as fungicides
02/08/2006CN1732147A Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
02/08/2006CN1732146A Cycloalkyl inhibitors of potassium channel function
02/08/2006CN1240679C 2- and 2,5-substituted phenylketoenols
02/08/2006CN1240672C Process for producing acidic N(long-chain acyl) amino acid
02/07/2006US6995285 ABCA-1 elevating compounds
02/07/2006US6995284 Synthesis of selective androgen receptor modulators
02/07/2006US6995271 An intermediate to an antidiabetic compound, by reacting methyl (2-hydrocarbyl-5-methyloxazol-2-yl)acetate with sodium borohydride (NaBH4) using tetrahydrofuran as a solvent and methanol as activator; acetate becomes a 2-hydroxy ethyl group
02/07/2006US6995151 Isophthalic acid derivatives as matrix metalloproteinase inhibitors
02/02/2006WO2006012227A2 Amido compounds and their use as pharmaceuticals
02/02/2006WO2006011669A1 Novel cinnamic acid related compounds
02/02/2006WO2006011035A1 Novel dipeptidyl peptidase iv inhibitors; process for their preparation and compositions containing them
02/02/2006WO2006010775A1 Tyrosine derivatives as ppar-gamma-modulators
02/02/2006WO2006010362A1 Amino adamantane derivatives, methods for the production and use thereof
02/02/2006US20060025630 Synthesis on N-vinyl formamide
02/02/2006US20060025594 Small molecule entry inhibitors
02/02/2006US20060025474 Bisphenyl compounds useful as vitamin D3 receptor agonists
02/02/2006US20060025472 Fungicidal carboxamides
02/02/2006US20060025396 Isophthalic acid derivatives as matrix metalloproteinase inhibitors
02/02/2006CA2574021A1 Tyrosine derivatives as ppar-gamma-modulators
02/02/2006CA2570694A1 Amido compounds and their use as pharmaceuticals
02/01/2006EP1620391A2 Cyclic derivatives as modulators of chemokine receptor activity
02/01/2006EP1476419B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
02/01/2006CN1729158A Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
02/01/2006CN1239572C Polyalkoxylated superamides optionally functionalised, use as emulsifiers
02/01/2006CN1239495C Fungicides for control of take-all disease of plants
02/01/2006CN1239469C Chiral amine compound and its synthesis and use
01/2006
01/31/2006US6992220 useful in the treatment or prevention or amelioration of one or more symptoms of hepatitis C.
01/31/2006US6992219 Invention provides five novel polymorphic forms of modafinil racemate called CRL 40476 form III, CRL 40476 form IV, CRL 40476 form V, CRL 40476 form VI, CRL 40476 form VII; treatment of sleep disorders
01/31/2006US6992207 Melphalan derivatives and their use as cancer chemotherapeutic drugs
01/31/2006CA2119261C Novel sidechain-bearing taxanes and intermediates thereof
01/26/2006WO2006010095A2 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
01/26/2006WO2006010094A1 Oxime derivative hydroxyethylamine aspartyl-protease inhibitors
01/26/2006WO2006009320A1 Process for production of powdery n-(long-chain acyl)- amino acids or salts thereof, powdery n-(long-chain acyl)amino acids or salts thereof, and facial cleansing powders
01/26/2006WO2006007957A1 Process for preparing monomers and polymers thereof
01/26/2006WO2005108409A3 Ferrocenyl ligands for homogeneous, enantioselective hydrogenation catalysts
01/26/2006US20060020131 Aryl amide, -sulfonamide, or -urea derivatives; antiproliferative, antitumor, anticarcinogenic, and/or antimetastasis agents
01/26/2006US20060020003 Biphenyloxy-acids
01/26/2006DE19612432B4 Verfahren zum Entfernen eines unlöslichen N-Vinylamidpolymers aus einer Anlage A method for removing an insoluble N-Vinylamidpolymers from a plant
01/26/2006DE102004030616A1 Verfahren zur Reinigung von Dimethylacetamid (DMAc) A process for the purification of dimethylacetamide (DMAc)
01/26/2006CA2573627A1 Process for preparing monomers and polymers using rhodococcus genus
01/26/2006CA2573138A1 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
01/26/2006CA2573128A1 Preparation of beta-amino acids having affinity for the alpha-2-delta protein
01/26/2006CA2572775A1 Oxime derivative hydroxyethylamine aspartyl-protease inhibitors
01/26/2006CA2513080A1 Inhibitors of the anandamide transporter
01/25/2006EP1618087A2 Antibacterial agents
01/25/2006EP1617803A2 Malonamides and malonamide derivatives as modulators of chemokine receptor activity
01/25/2006EP1097158B1 Ligands for metals and metal-catalyzed processes
01/25/2006CN1726185A Formulations comprising selective androgen receptor modulators and using method thereof
01/25/2006CN1724511A Method of extracting capsaicin and capsaithin from red pepper
01/25/2006CN1724507A Optically pure alpha-difluoromethylamine and method of highly stereo-seective preparation
01/24/2006US6989461 Containing a transition metal compound selected from ruthenium and rhodium, a chiral ligand containing a cyclic (R'R"NP)-(O-R-O-) group
01/24/2006US6989384 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
01/19/2006US20060014743 Methods of preventing bacterial infections with florfenicol-type antibiotics
01/19/2006CA2573243A1 Method for producing enantiomeric form of 2, 3-diaminopropionic acid derivatives
01/18/2006EP1615915A1 Phenacyl 2-hydroxy-3-diaminoalkanes
01/18/2006EP1615880A2 Preparation and purification of synthetic capsaicin
01/18/2006EP1615876A1 Method for the purification of dimethylacetamide (dmac)
01/18/2006EP0973727B8 Activated iododerivatives for the treatment of cancer and aids
01/18/2006CN1723207A Inhibitors of histone deacetylase
01/18/2006CN1723193A Novel polycyclic compounds which modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof
01/18/2006CN1723192A Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives as pharmaceutical agents
01/18/2006CN1723191A Vermin-repellant compositions and compounds
01/18/2006CN1723190A Polymorphic forms of nateglinide
01/18/2006CN1721392A Process for preparing N,N-dimethyl chloroacetamide
01/17/2006US6987084 Photo-labile pro-fragrance conjugates
01/17/2006CA2172014C Preparation of .alpha.-chloroalkyl aryl ketones
01/12/2006WO2006003923A1 Substituted benzene compound
01/12/2006WO2006003194A1 Process for preparing amines and a carboxamide thereof
01/12/2006US20060009488 Prodrugs of selective androgen receptor modulators and methods of use thereof
01/12/2006US20060009484 Novel polycyclic compounds which modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof
01/12/2006US20060009476 Methods for producing phenylalanine derivatives having a quinazolinedione skeleton and intermediates for production thereof
01/12/2006CA2566648A1 Guanylhydrazone salts, compositions, processes of making and methods of using
01/11/2006EP1613589A1 Novel diphenyl azetidinone with improved physiological characteristics, corresponding production method, medicaments containing said compound and use of the latter
01/11/2006EP0956318B1 Radiation-curable composition
01/11/2006CN1720252A Transition metal complex having diphosphine complex as ligand
01/11/2006CN1236000C Electronic donor compound capable of solidifying
01/11/2006CN1235887C Preparation method of xazolyl alcohol derivatives
01/10/2006USRE38934 Method and reagents for N-alkylating ureides
01/10/2006US6984755 reacting ethylene, carbon monoxide, and propanoic acid in presence of catalyst containing bidentate phosphate ligand
01/10/2006US6984715 for production of polyurethane coatings; abrasion/solvent/weather resistance
01/10/2006US6984664 Reduce side effect; analgesics
01/10/2006US6984645 Aryl carboxylic acids and tetrazoles for treating diabetes, especially type II diabetes
01/05/2006WO2006002361A2 2-methylpropanamides and their use as pharmaceuticals
01/05/2006WO2006000392A1 Method for the purification of dimethylacetamide (dmac)
01/05/2006WO2006000324A2 New mao-b inhibitors
01/05/2006WO2006000288A1 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes
01/05/2006US20060004103 Method for producing lysine derivative
01/05/2006US20060004102 Crystal structure; comminution in solvent; crystallization; antidiabetic agents